Dow Up 0.26% Nasdaq Down 1.07%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
160.42 2.30(1.41%) Sep 15, 4:00PM EDT
Prev Close:162.72
Open:162.02
Bid:120.00 x 200
Ask:N/A
1y Target Est:198.65
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:157.30 - 162.02
52wk Range:100.89 - 185.43
Volume:1,145,789
Avg Vol (3m):1,163,320
Market Cap:31.73B
P/E (ttm):96.99
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 1.41%31.73B
AMGN104.80B
BAX40.38B

Key Statistics

Forward P/E (1 yr):27.90
P/S (ttm):16.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback